Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity

Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity

US Patent 6350750 · Granted Feb 26, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused heterocyclic derivatives as S1P modulators2020
Fused heterocyclic derivatives as S1P modulators2017
(Thio)morpholine derivatives as S1P modulators2016
Fused heterocyclic derivatives as S1P modulators2015
(Thio)morpholine derivatives as S1P modulators2015
Fused heterocyclic derivatives as S1P modulators2014
Heterocyclic compounds with affinity to muscarinic receptors2014
Heterocyclic compounds with affinity to muscarinic receptors2013
Heterocyclic compounds with affinity to muscarinic receptors2011
Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptor2011
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists2010
Piperazine and piperidine compounds2010